The information provided in this report is taken from www.sec.gov and many other data providers. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.
Leap Therapeutics, Inc(NASDAQ:LPTX) 
Leap Therapeutics, Inc., a biopharmaceutical company, acquires and develops therapies for the treatment of cancer. Its lead clinical stage programs include DKN-01, a monoclonal antibody that inhibits Dickkopf-related protein 1 that is in multiple clinical trials for treating esophagogastric cancer, ...
Website: http://www.leaptx.com
Founded: 2011
Full Time Employees: 24
Sector: Healthcare
Industry: Biotechnology
Leap Therapeutics Days Payable Outstanding ttm (DPO)
Leap Therapeutics Days Receivable Outstanding ttm (DSO)
Leap Therapeutics Op Cashflow Per Share ttm
Leap Therapeutics Free Cashflow Per Share ttm
Leap Therapeutics Cash Per Share ttm
Leap Therapeutics P/S ratio ttm
Leap Therapeutics (GAAP) P/E ratio ttm
Leap Therapeutics P/B ratio ttm
No extra charts and metrics for this ticker.